DWP14012

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for DWP14012, covering 2017-04-25 to 2024-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer [Phase 3]